study focused patients aged 18 65 schizophrenia , requiring treatment due inadequate response intolerability prior medication , excluding hypersensitivity study drugs , acute suicidality , involuntary treatment , significant medical conditions interacting antipsychotic treatment . Patients randomized two groups , one receiving conventional antipsychotic new antipsychotic , 136 patients 14 centers Germany participating . randomization exclude patients tardive dyskinesia . Data collected multiple points , including sociodemographic details , utilized various scales assessment , PSP , SF-36 , CGI , others . primary endpoint analyzed using AUC values 24-week period , missing data handled imputation . study adhered ethical guidelines managed statistically SAS version 9.4 .